Drugs / AD07010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03784885 | Sep 2017 → Jan 2018 | influenza | Advagene Biopharma Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD07010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03784885 ↗ |
| Modality | Protein / enzyme biologic | “A protein based adjuvant” NCT03784885 ↗ |
| Route | Intranasal | “given intranasally in healthy adult volunteers” NCT03784885 ↗ |